Crystal structure of (E)-7-fluoro-2(4-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O

被引：0
作者：
Wei, Pan-Pan [1 ]
Meng, Qing-Guo [1 ]
Wang, Bao-Gang [2 ]
Hou, Gui-Ge [3 ]
Song, Ya-Bin [2 ]
机构：
[1] Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & Bi, Sch Pharm, Minist Educ, Yantai, Peoples R China
[2] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
[3] Binzhou Med Univ, Sch Pharm, Yantai 264003, Peoples R China
来源：
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2023年 / 238卷 / 04期
基金：
中国国家自然科学基金;
关键词：
3,5-BIS(ARYLIDENE)-4-PIPERIDONES; DERIVATIVES; AGENTS;
D O I：
10.1515/ncrs-2023-0159
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
C17H12F2O, triclinic, P1 ($) over bar (no. 2), a = 7.9570(14) A, b = 8.9872(19) A, c = 9.3974(16) A, alpha = 94.467(16)degrees, beta = 96.737(14)degrees,gamma = 103.162(16)degrees, V = 646.0(2) A(3), Z = 2, R-gt(F) = 0.0417, wR(ref)(F-2) = 0.1112, T = 293 K.
引用
收藏
页码：701 / 703
页数：3
相关论文
共 50 条
  • [31] 2-(2-Hydroxyphenyl)-3,4-dihydroisoquinolin-1(2H)-one
    Yang, Jian
    Ma, Yanni
    Pan, Meng
    Cao, Fangjun
    Zhou, Le
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2721 - +
  • [32] Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one-dichloromethane (1/1), C26H20Cl2F3NO3S
    Yan, Wei-Bin
    Liu, Yong-Jun
    Hou, Gui-Ge
    Cong, Wei
    Meng, Qing-Guo
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (04): : 947 - 949
  • [33] Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3,5-bis(4-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C26H20Cl3F2NO3S
    Zhang, Li-Xia
    Hou, Yun
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (04): : 891 - 893
  • [34] Crystal structure of (E)-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5(2H)-one, C23H25NO5
    Xia, De-Li
    Wang, Ji-Peng
    Yu, Wen-Xiao
    Wang, Mei-Dan
    Gao, Hao-Xue
    Cui, Yao-Tian
    Hou, Gui-Ge
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (06): : 1133 - 1136
  • [35] Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one, C24H18F2N2O3S
    Sun, Yue
    Liu, Yin-Kai
    Li, Jia-Dong
    Meng, Qing-Guo
    Hou, Gui-Ge
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (02): : 377 - 379
  • [36] Crystal structure of 3-(pyrazin-2-ylamino)-2-benzofuran-1(3H)-one, C12H9N3O2
    Betrow, Abdulhakem
    Karama, Usama
    Al-Noaimi, Mousa
    Awwadi, Firas F.
    Hammouti, Belkheir
    Radi, Smaail
    Ben Hadda, Taibi
    Warad, Ismail
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2014, 229 (04): : 385 - 386
  • [37] Crystal structure of 4-((E)-((E)-5-(2-fluorobenzylidene)-1-((4-fluorophenyl) sulfonyl)-4-oxopiperidin-3-ylidene)methyl)benzonitrile, C26H18F2N2O3S
    Liu, Lian-Dong
    Liu, Shu-Lian
    Hou, Gui-Ge
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2018, 233 (06): : 1063 - 1065
  • [38] Crystal structure of 3-methyl-2H-chromen-2-one, C10H8O2
    Zeng Fan-Xin
    Nie Xu-Liang
    Shang-guan Xin-Chen
    Yin Zhong-Ping
    Peng Da-Yong
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2016, 231 (03): : 975 - 976
  • [39] Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2
    Wang, An-Qi
    Gao, Ru-Ning
    Luan, Qing-Hao
    Wang, Ze-Ping
    Li, Xiao-Ming
    Hou, Gui-Ge
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (02): : 381 - 384
  • [40] The crystal structure of (E)-4-fluoro-N′-(1-(2-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
    Li, Xiaohua
    Zhao, Xin
    Tang, Wenqiang
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2023, 238 (04): : 809 - 811
12345